Skip to main content
Erschienen in: Emergency Radiology 6/2010

01.11.2010 | Pictorial Essay

Subtrochanteric femoral insufficiency fractures related to the use of long-term bisphosphonates: a pictorial review

verfasst von: Nanda Venkatanarasimha, Gemma Miles, Priya Suresh

Erschienen in: Emergency Radiology | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Sub-trochanteric femoral fractures as a complication of long standing bisphosphonate therapy are rare. Drug regulatory authorities like MHRA in the UK (Medicines and Healthcare products Regulatory Agency) have recently alerted specialists about this complication. We describe and illustrate the plain radiographic, CT and MRI features and emphasize the role of imaging in the accurate diagnosis of this new type of insufficiency fractures. There is paucity of radiology literature on this topic and hence awareness of the typical imaging features helps to prevent misdiagnosis and delayed treatment. Our patients were on bisphosphonates (alendronate) for more than 3 years duration and presented with anterolateral thigh pain to the emergency department.
Literatur
1.
Zurück zum Zitat Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348:1535–1541CrossRefPubMed Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348:1535–1541CrossRefPubMed
2.
Zurück zum Zitat Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY (2005) Severely suppressed bone turnover: potential complication of alendronate therapy. J Clic Endocrinol Metab 90:1294–1301CrossRef Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY (2005) Severely suppressed bone turnover: potential complication of alendronate therapy. J Clic Endocrinol Metab 90:1294–1301CrossRef
3.
Zurück zum Zitat Koh JS, Goh SK, Png MA, Kwek EB, Howe TS (2010) Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture? J Orthop Trauma 24:75–81CrossRefPubMed Koh JS, Goh SK, Png MA, Kwek EB, Howe TS (2010) Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture? J Orthop Trauma 24:75–81CrossRefPubMed
4.
Zurück zum Zitat Currey JD (1984) Effects of differences in mineralisation on the mechanical properties of bone. Phil Trans R Soc Lond Biol Sci 304:509–518CrossRef Currey JD (1984) Effects of differences in mineralisation on the mechanical properties of bone. Phil Trans R Soc Lond Biol Sci 304:509–518CrossRef
5.
Zurück zum Zitat Wasserman N, Yerramshetty J, Akkus O (2005) Microcracks colocalize within highly mineralised regions of cortical bone tissue. Eur J Morphol 42:43–51CrossRefPubMed Wasserman N, Yerramshetty J, Akkus O (2005) Microcracks colocalize within highly mineralised regions of cortical bone tissue. Eur J Morphol 42:43–51CrossRefPubMed
6.
Zurück zum Zitat Mashiba T, Mori S, Burr DB, Komatsubara S, Cao Y, Manabe T, Norimatsu H (2005) The effects of suppressed bone remodelling by bisphosphonates on microdamage accumulation and degree of mineralisation in the cortical bone of dog rib. J Bone Miner Metab 23(Suppl):36–42CrossRefPubMed Mashiba T, Mori S, Burr DB, Komatsubara S, Cao Y, Manabe T, Norimatsu H (2005) The effects of suppressed bone remodelling by bisphosphonates on microdamage accumulation and degree of mineralisation in the cortical bone of dog rib. J Bone Miner Metab 23(Suppl):36–42CrossRefPubMed
7.
Zurück zum Zitat Ensrud KE, Barrett-Connor EL, Schwartz A, Santora AC, Bauer DC, Suryawanshi S, Feldstein A, Haskell WL, Hochberg MC, Torner JC, Lombardi A, Black DM (2004) Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension. J Bone Miner Res 19:1259–1269CrossRefPubMed Ensrud KE, Barrett-Connor EL, Schwartz A, Santora AC, Bauer DC, Suryawanshi S, Feldstein A, Haskell WL, Hochberg MC, Torner JC, Lombardi A, Black DM (2004) Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension. J Bone Miner Res 19:1259–1269CrossRefPubMed
8.
Zurück zum Zitat Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, Satterfield S, Wallace RB et al (2006) Effects of continuing of stopping alendronate after 5 years of treatment: the fracture intervention trial long-term extension (FLEX): a randomised trial. JAMA 296:2968–2969CrossRef Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, Satterfield S, Wallace RB et al (2006) Effects of continuing of stopping alendronate after 5 years of treatment: the fracture intervention trial long-term extension (FLEX): a randomised trial. JAMA 296:2968–2969CrossRef
9.
Zurück zum Zitat Whyte MP, Wenkert D, Clemens KL, McAllister WH, Mumm S (2003) Bisphosphonate-induced osteopetrosis. N Engl J Med 349:457–463CrossRefPubMed Whyte MP, Wenkert D, Clemens KL, McAllister WH, Mumm S (2003) Bisphosphonate-induced osteopetrosis. N Engl J Med 349:457–463CrossRefPubMed
10.
Zurück zum Zitat Boivin G, Meunier PJ (2002) Changes in bone remodelling rate influence the degree of mineralization of bone. Connect tissue Res 43:535–537PubMed Boivin G, Meunier PJ (2002) Changes in bone remodelling rate influence the degree of mineralization of bone. Connect tissue Res 43:535–537PubMed
11.
Zurück zum Zitat Akkus O, Polyakova-Akkus A, Adar F, Schaffler MB (2003) Aging and microstructural compartments in human compact bone. J Bone Miner Res 18:1012–1019CrossRefPubMed Akkus O, Polyakova-Akkus A, Adar F, Schaffler MB (2003) Aging and microstructural compartments in human compact bone. J Bone Miner Res 18:1012–1019CrossRefPubMed
12.
Zurück zum Zitat Richer E, Lewis M, Odvina C, Vasquez MA, Smith BJ, Peterson RD et al (2005) Reduction in normalized bone elasticity long-term bisphosphonate treatment as measured by ultrasound critical angle reflectometry. Osteoporosis International 16:1384–1392CrossRefPubMed Richer E, Lewis M, Odvina C, Vasquez MA, Smith BJ, Peterson RD et al (2005) Reduction in normalized bone elasticity long-term bisphosphonate treatment as measured by ultrasound critical angle reflectometry. Osteoporosis International 16:1384–1392CrossRefPubMed
13.
Zurück zum Zitat Pauwels F (1948) Die bedeutung der bauprinzipien des stutz-und bewegungsapparates fur die beanspruchung der rohrenknochen. Anat Embryol 114:1–2CrossRef Pauwels F (1948) Die bedeutung der bauprinzipien des stutz-und bewegungsapparates fur die beanspruchung der rohrenknochen. Anat Embryol 114:1–2CrossRef
14.
Zurück zum Zitat Goh SK, Yank KY, Koh JS, Wong MK, Chua SY, Chua DT, Howe TS (2007) Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br 89:349–353CrossRefPubMed Goh SK, Yank KY, Koh JS, Wong MK, Chua SY, Chua DT, Howe TS (2007) Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br 89:349–353CrossRefPubMed
15.
Zurück zum Zitat Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG (2008) Low-energy femoral shaft fractures associated with alendronate use. J Orth Trauma 22:346–350CrossRef Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG (2008) Low-energy femoral shaft fractures associated with alendronate use. J Orth Trauma 22:346–350CrossRef
16.
Zurück zum Zitat Kwek EB, Goh SK, Koh JS, Png MA, Howe TS (2008) An emerging pattern of subtrocahanteric stress fractures: a long-term complication of alendronate therapy? Injury 39:224–231CrossRefPubMed Kwek EB, Goh SK, Koh JS, Png MA, Howe TS (2008) An emerging pattern of subtrocahanteric stress fractures: a long-term complication of alendronate therapy? Injury 39:224–231CrossRefPubMed
17.
Zurück zum Zitat Porrino JA, Kohl CA, Taljanovic M, Rogers LF (2010) Diagnosis of proximal femoral insufficiency fractures in patients receiving bisphosphonate therapy. Am J Roentgenol 194:1061–1064CrossRef Porrino JA, Kohl CA, Taljanovic M, Rogers LF (2010) Diagnosis of proximal femoral insufficiency fractures in patients receiving bisphosphonate therapy. Am J Roentgenol 194:1061–1064CrossRef
18.
Zurück zum Zitat Bush LA, Chew FS (2008) Subtrochanteric femoral insufficiency fracture following bisphosphonate therapy for osseous metastases. Radiol Case Rep 3:232 Bush LA, Chew FS (2008) Subtrochanteric femoral insufficiency fracture following bisphosphonate therapy for osseous metastases. Radiol Case Rep 3:232
19.
Zurück zum Zitat Visekruna M, Wilson D, McKiernan FE (2008) Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab 93:2948–2952CrossRefPubMed Visekruna M, Wilson D, McKiernan FE (2008) Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab 93:2948–2952CrossRefPubMed
20.
Zurück zum Zitat Tilstone C (2009). Drug safety update. MRHA and CHM 2; issue 8:8 Tilstone C (2009). Drug safety update. MRHA and CHM 2; issue 8:8
Metadaten
Titel
Subtrochanteric femoral insufficiency fractures related to the use of long-term bisphosphonates: a pictorial review
verfasst von
Nanda Venkatanarasimha
Gemma Miles
Priya Suresh
Publikationsdatum
01.11.2010
Verlag
Springer-Verlag
Erschienen in
Emergency Radiology / Ausgabe 6/2010
Print ISSN: 1070-3004
Elektronische ISSN: 1438-1435
DOI
https://doi.org/10.1007/s10140-010-0890-y

Weitere Artikel der Ausgabe 6/2010

Emergency Radiology 6/2010 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.